2010年下半年,全球共首次批准了10个新分子实体和2个新生物制剂(表1),其中包括2个心血管系统疾病治疗新药、2个抗感染新药、2个精神神经系统疾病治疗新药、2个代谢疾病治疗新药、1个抗 In the second half of 2010, a total of 10 new molecular entities and 2 new biological agents were approved for the first time in the world (Table 1), including 2 new drugs for the treatment of cardiovascular diseases, 2 new drugs for anti-infectives and 2 treatments for diseases of the nervous system New drugs, two metabolic disease treatment of new drugs, 1 anti